Opening of our new premises
22 June 2023We had the great pleasure of celebrating the opening of our new premises on 15 June. ☀
A great opportunity to present our new state-of-the-art facility and headquarters.
This brand new building is intended to support the preclinical development of biotherapies, vaccines, and gene therapies, and to become a major player in the field of infectious diseases and central nervous system disorders.
Heartfelt thanks to our partners for their presence, especially: the Région Auvergne-Rhône-Alpes, the Préfecture Auvergne-Rhône-Alpes, Lyonbiopôle, Motac Neuroscience Ltd, Active Biomarkers, virnext, Oncodesign Services, BIOASTER, Cynbiome and AFSSI Sciences de la Vie.
We would also like to express our gratitude to all those who trust us every day and who have contributed to making this day unforgettable…
Another significant milestone achieved for Cynbiose, Hugues Contamin, and his entire team!
